These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7919942

  • 1. Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats.
    Radhakishun FS, Westerink BH, Stoof JC, Wolterink G, van Ree JM.
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):127-36. PubMed ID: 7919942
    [Abstract] [Full Text] [Related]

  • 2. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin.
    Radhakishun FS, Westerink BH, van Ree JM.
    Neurosci Lett; 1988 Jul 08; 89(3):328-34. PubMed ID: 2901702
    [Abstract] [Full Text] [Related]

  • 3. The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
    Radhakishun FS, Stoof JC, Mulder AH, Versteeg DH, van Ree JM.
    Brain Res; 1987 Nov 24; 426(2):235-42. PubMed ID: 2961411
    [Abstract] [Full Text] [Related]

  • 4. Desenkephalin-gamma-endorphin and neuroleptics counteract the DP-7-ATN-induced hypomotility after intra-accumbens treatment.
    Radhakishun FS, Horn AS, Van Ree JM.
    Eur J Pharmacol; 1988 Feb 16; 147(1):137-40. PubMed ID: 2897307
    [Abstract] [Full Text] [Related]

  • 5. Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens.
    Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS.
    Psychopharmacology (Berl); 1991 Feb 16; 104(1):51-6. PubMed ID: 1882003
    [Abstract] [Full Text] [Related]

  • 6. Non-opiate beta-endorphin fragments and dopamine--III. gamma-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens.
    Van Ree JM, Caffé AR, Wolterink G.
    Neuropharmacology; 1982 Nov 16; 21(11):1111-7. PubMed ID: 6184640
    [Abstract] [Full Text] [Related]

  • 7. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1989 Nov 16; 28(11):1223-9. PubMed ID: 2574424
    [Abstract] [Full Text] [Related]

  • 8. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens.
    Spanagel R, Herz A, Shippenberg TS.
    Eur J Pharmacol; 1990 Nov 06; 190(1-2):177-84. PubMed ID: 1981749
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis.
    Spanagel R, Herz A, Shippenberg TS.
    Eur J Pharmacol; 1991 Aug 06; 200(2-3):319-24. PubMed ID: 1782993
    [Abstract] [Full Text] [Related]

  • 10. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I, Van Ree JM.
    Neuropharmacology; 1984 May 06; 23(5):511-6. PubMed ID: 6204246
    [Abstract] [Full Text] [Related]

  • 11. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS, Van Ree JM.
    Eur J Pharmacol; 1987 May 07; 137(1):41-7. PubMed ID: 3609134
    [Abstract] [Full Text] [Related]

  • 12. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
    Boldry RC, Uretsky NJ.
    Neuropharmacology; 1988 Jun 07; 27(6):569-77. PubMed ID: 2901677
    [Abstract] [Full Text] [Related]

  • 13. Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade.
    Dringenberg HC, de Souza-Silva MA, Schwarting RK, Huston JP.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct 07; 358(4):423-9. PubMed ID: 9826064
    [Abstract] [Full Text] [Related]

  • 14. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.
    Imperato A, Di Chiara G.
    J Pharmacol Exp Ther; 1986 Oct 07; 239(1):219-28. PubMed ID: 3761194
    [Abstract] [Full Text] [Related]

  • 15. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG, Arborelius L, Höök BB, Hacksell U, Svensson TH.
    J Neural Transm (Vienna); 1996 Oct 07; 103(5):541-54. PubMed ID: 8811500
    [Abstract] [Full Text] [Related]

  • 16. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM, Elands J, Király I, Wolterink G.
    Eur J Pharmacol; 1989 Aug 03; 166(3):441-52. PubMed ID: 2572429
    [Abstract] [Full Text] [Related]

  • 17. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ, Taylor DA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May 03; 355(5):582-8. PubMed ID: 9151296
    [Abstract] [Full Text] [Related]

  • 18. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission.
    Piepponen TP, Honkanen A, Kivastik T, Zharkovsky A, Turtia A, Mikkola JA, Ahtee L.
    Pharmacol Biochem Behav; 1999 Jun 03; 63(2):245-52. PubMed ID: 10371653
    [Abstract] [Full Text] [Related]

  • 19. Regional amines levels in the rat brain following intra-accumbens cholecystokinin and intraperitoneal amphetamine pre-treatment.
    Heidbreder C, Gewiss M, De Potter W, De Witte P.
    Arch Int Physiol Biochim Biophys; 1992 Jun 03; 100(3):267-73. PubMed ID: 1382678
    [Abstract] [Full Text] [Related]

  • 20. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A, Baranyi M, Windisch K, Petkova-Kirova P, Gagov H, Kalfin R.
    Brain Res Bull; 2017 Sep 03; 134():246-252. PubMed ID: 28802898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.